Syra Health Corp - 2025年季度报告

FORM10-Q (Mark One) SYRA HEALTH CORP. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ PageNo.PART I. FINANCIAL INFORMATIONItem 1.Financial StatementsF-1Condensed Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 2024F-1Condensed Statements of Operations for the Three Months ended March 31, 2025 and 2024 (Unaudited)F-2Statements of Changes in Stockholders’ Equity (Deficit) for the Three Months ended March 31, 2025 and 2024(Unaudited)F-3Condensed Statements of Cash Flows for the Three Months ended March 31, 2025 and 2024 (Unaudited)F-4Notes to the Condensed Financial Statements (Unaudited)F-5Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations4Item 3.Quantitative and Qualitative Disclosures About Market Risk9Item 4.Controls and Procedures9PART II. OTHER INFORMATION10Item 1.Legal Proceedings10Item 1A.Risk Factors10Item 2.Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities10Item 3.Defaults Upon Senior Securities10Item 5.Other Information10Item 6.Exhibits11Signatures122 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA This Quarterly Report on Form 10-Q contains forward-looking statements which are made pursuant to the safe harbor provisions ofSection 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934,as amended (the “Exchange Act”). These statements may be identified by such forward-looking terminology as “may,” “should,”“expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these termsor other comparable terminology. Our forward-looking statements are based on a series of expectations, assumptions, estimates andprojections about our company, are not guarantees of future results or performance and involve substantial risks and uncertainty. We ●our projected financial position and estimated cash burn rate;●our estimates regarding expenses, future revenues and capital requirements;●our ability to continue as a going concern;●our need to raise substantial additional capital to fund our operations;●our ability to compete in the healthcare industry;●the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; All of our forward-looking statements are as of the date of this Quarterly Report on Form 10-Q only. In each case, actual results maydiffer materially from such forward-looking information. We can give no assurance that such expectations or forward-lookingstatements will prove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks anduncertainties referred to in this Quarterly Report on Form 10-Q or included in our other public disclosures or our other periodic reportsor other documents or filings filed with or furnished to the U.S. Securities and Exchange Commission (the “SEC”) could materiallyand adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do notundertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, This Quarterly Report on Form 10-Q may include market data and certain industry data and forecasts, which we may obtain frominternal company surveys, market research, consultant surveys, publicly available information, reports of governmental agencies andindustry publications, articles and surveys. Industry surveys, publications, consultant surveys and forecasts generally state that theinformation contained therein has been obtained from sources believed to be reliable, but the accuracy and completeness of such SYRA HEALTH CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS Note 1 –Nature of Business and Significant Accounting Policies Nature of Business Syra Health Corp. (“Syra” or the “Company”) was incorporated in the state of Indiana on November 20, 2020 to provide workforcestaffing solutions, health education and healthcare research consulting services to mental health hospitals and organizations, includinggovernment agencies, integrated health networks, managed care entities and pharmaceutical manufacturers. On March 11, 2022, the Basis of Presentation The accompanying interim consolidated financial statements have been prepared in accordance with accounting principles generallyaccepted in the United States of America (“U.S. GAAP”) and should be read in conjunction with the financial statements and notesthereto included in our Annual Report on Form 10-K f